Naftopidil hydrochloride (ab120756)

概述

  • 产品名称Naftopidil hydrochloride
  • 描述
    α1 Adrenoceptor antagonist
  • 生物学描述α1 Adrenoceptor antagonist. pKi values are 3.7, 20 and 1.2 for α1a, α1b and α1d, respectively. Orally active. Implicated in benign prostate hyperplasia and bladder obstruction. Antihypertensive.
  • 纯度> 98%

性能

    Naftopidil hydrochloride (ab120756)参考文献

    This product has been referenced in:
    • Kanda H  et al. Naftopidil, a selective alpha-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest. Int J Cancer 122:444-51 (2008). Read more (PubMed: 17918159) »
    • Takei R  et al. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol 79:447-54 (1999). Read more (PubMed: 10361884) »
    • Yamada S  et al. Binding characteristics of naftopidil and alpha 1-adrenoceptor antagonists to prostatic alpha-adrenoceptors in benign prostatic hypertrophy. Life Sci 50:127-35 (1992). Read more (PubMed: 1370569) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120756.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"